Data as of Nov 21
| -0.12 / -1.19%|
The 5 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +10.55% increase from the last price of 9.95.
The current consensus among 6 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.